↓ Skip to main content

Case report: Ruxolitinib as first-line therapy for secondary hemophagocytic lymphohistiocytosis in patients with AIDS

Overview of attention for article published in Frontiers in immunology, October 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter
8 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
4 Mendeley